|
|
 |
|
Viewing report
|
|
 |
Medical Research, Diagnostic Substances & Life Science Tools Report
Wall Street Transcript, The, Oct 2011, Pages: 26
The Wall Street Transcript has just published its Medical Research, Diagnostic Substances & Life Science Tools Report, a report offering a timely review of the sector to serious investors and industry executives. This 26-page feature contains industry commentary through in-depth interviews with 4 leading Analysts; and top management from 3 Sector Firms.
Topics covered:
- Health Care Consolidation Activity
- Volatility Along the Market-Cap Spectrum
- Hospital Capital Spending and Utilization Rates
- Cost Reduction Amid Reimbursement Uncertainty
|
 |
|
|